Molecular glues for an oncology target — discovered directly in living cells
Using DELs in Cells – Molecular Glue Direct, Vipergen screened an oncology target in triplex with two E3 ubiquitin ligases and identified 89 hits…
DEL in action – selected case studies
How leading pharmaceutical and biotech partners are accelerating early drug discovery with Vipergen’s DEL technology and integrated screening platform.
Novel inhibitors of an inflammatory kinase – found first try
Using Binder Trap Enrichment screening against a 12.6 million-compound yoctoReactor library, Vipergen identified selective, single-digit nanomolar…